Director Reed N. Wilcox filed a Form 4 with the SEC on November 13, 2026, disclosing the grant of a stock option for 3,395 shares of Clene Inc. common stock on November 12, 2026.

Key Highlights

  • Reporting person: Reed N. Wilcox, identified as a Director of Clene Inc. (NASDAQ:CLNN)
  • Transaction date: November 12, 2026
  • Securities acquired: A stock option for 3,395 shares of common stock, transaction code "A" (acquired)
  • Exercise price: $4.00 per share
  • Vesting: The options vest immediately upon grant, according to the filing
  • Expiration date: November 11, 2036
  • Post-transaction holdings: 3,395 derivative securities beneficially owned, held directly

Clene Director Reed Wilcox Receives Immediately Vesting Option Grant Under 2020 Stock Plan

According to the Form 4 filed on November 13, 2026, Reed N. Wilcox, a director of Clene Inc., received a stock option grant on November 12, 2026 covering 3,395 shares of Clene Inc. common stock. The filing reports the transaction under code "A," indicating an acquisition of derivative securities. The option was granted with an exercise price of $4.00 per share and carries an expiration date of November 11, 2036.

The filing's explanation of responses states: "This option was granted on November 12, 2026 as an option for 3,395 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $4.00 per share. The options vest immediately upon grant." The price of the derivative security at the time of the transaction is listed as $0, as reported in the filing.

Following the reported transaction, Wilcox beneficially owns 3,395 derivative securities in direct form, according to the filing. No non-derivative securities transactions were reported in Table I of the form. The filing was signed by Jerome T. Miraglia as power of attorney on November 13, 2026, the same date it was submitted to the SEC.

What Was Disclosed

Clene Inc. director Reed N. Wilcox disclosed the receipt of a stock option for 3,395 shares at an exercise price of $4.00, granted November 12, 2026 under the Clene Inc. Amended 2020 Stock Plan, with immediate vesting and expiration on November 11, 2036.